It increased the expression of glutamate receptor 1 (GluR1), glutamate receptor 2 (GluR2) in the rat brain, and was able to reverse the depressive-like behavior caused by the hypercholinergic state in the depression model [70, 71]. The gene discussed is GRIA2; the disease is depressive symptom measurement.